Condition
Diabetic Neuralgia
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (2)
P 3 (1)
Trial Status
Completed4
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00501202Phase 2Completed
Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
NCT02107469Not ApplicableCompleted
A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy
NCT00861952Phase 3Withdrawn
Neuragen for Peripheral Diabetic Neuropathy
NCT00507936Phase 2CompletedPrimary
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00539175Not ApplicableCompleted
Treatment of Painful Diabetic Neuropathy With Photon Stimulation
Showing all 5 trials